Amgen beats Sanofi, Regeneron at cholesterol drug trial

(Reuters) - A federal jury ruled in favor of Amgen Inc in its lawsuit accusing Sanofi SA and Regeneron Pharmaceuticals Inc of infringing patents for antibodies related to a cholesterol drug, the defendants said on Wednesday.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro